Discoidin domain receptors in disease

Matrix Biology

Volumn 34, Issue , 2014, Pages 185-192

  Borza, Corina M ^a   Pozzi, Ambra ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cancer; Fibrosis; Inflammation; Kidney; Matrix; Signaling

Indexed keywords

DISCOIDIN; DISCOIDIN DOMAIN RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; DDR1 PROTEIN, HUMAN; DISCOIDIN RECEPTOR; LECTIN RECEPTOR; PROTEIN TYROSINE KINASE;

ARTICLE; ATHEROSCLEROSIS; CANCER GROWTH; CELL FUNCTION; CELL MIGRATION; CYTOKINE RELEASE; DISEASE COURSE; EXTRACELLULAR MATRIX; FIBROSIS; HOMEOSTASIS; HUMAN; INFLAMMATION; KIDNEY INJURY; LUNG FIBROSIS; NEOPLASM; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; CELL PROLIFERATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY;

MUS;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; INFLAMMATION; MICE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, MITOGEN; SIGNAL TRANSDUCTION;

EID: 84900340780     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.12.002     Document Type: Article

References (93)

1. Abbonante V., Gruppi C., Rubel D., Gross O., Moratti R., Balduini A. Discoidin domain receptor 1 protein is a novel modulator of megakaryocyte-collagen interactions. J. Biol. Chem. 2013, 288:16738-16746.
2. Abdulhussein R., McFadden C., Fuentes-Prior P., Vogel W.F. Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor. J. Biol. Chem. 2004, 279:31462-31470.
3. Ali B.R., Xu H., Akawi N.A., John A., Karuvantevida N.S., Langer R., Al-Gazali L., Leitinger B. Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients. Hum. Mol. Genet. 2010, 19:2239-2250.
4. Alves F., Vogel W., Mossie K., Millauer B., Hofler H., Ullrich A. Distinct structural characteristics of Discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene 1995, 10:609-618.
5. Alves F., Saupe S., Ledwon M., Schaub F., Hiddemann W., Vogel W.F. Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: differential expression in human colon cancer cell lines. FASEB J. 2001, 15:1321-1323.
6. Avivi-Green C., Singal M., Vogel W.F. Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 2006, 174:420-427.
7. Bantscheff M., Eberhard D., Abraham Y., Bastuck S., Boesche M., Hobson S., Mathieson T., Perrin J., Raida M., Rau C., Reader V., Sweetman G., Bauer A., Bouwmeester T., Hopf C., Kruse U., Neubauer G., Ramsden N., Rick J., Kuster B., Drewes G. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 2007, 25:1035-1044.
8. Borza C.M., Su Y., Chen X., Yu L., Mont S., Chetyrkin S., Voziyan P., Hudson B.G., Billings P.C., Jo H., Bennett J.S., Degrado W.F., Eckes B., Zent R., Pozzi A. Inhibition of integrin alpha2beta1 ameliorates glomerular injury. J. Am. Soc. Nephrol. 2012, 23:1027-1038.
9. Cader F.Z., Vockerodt M., Bose S., Nagy E., Brundler M.A., Kearns P., Murray P.G. The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1. Blood 2013, 122(26):4237-4245.
10. Carafoli F., Hohenester E. Collagen recognition and transmembrane signalling by discoidin domain receptors. Biochim. Biophys. Acta 2013, 1834:2187-2194.
11. Carafoli F., Bihan D., Stathopoulos S., Konitsiotis A.D., Kvansakul M., Farndale R.W., Leitinger B., Hohenester E. Crystallographic insight into collagen recognition by discoidin domain receptor 2. Structure 2009, 17:1573-1581.
12. Carafoli F., Mayer M.C., Shiraishi K., Pecheva M.A., Chan L.Y., Nan R., Leitinger B., Hohenester E. Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling. Structure 2012, 20:688-697.
13. Curat C.A., Vogel W.F. Discoidin domain receptor 1 controls growth and adhesion of mesangial cells. J. Am. Soc. Nephrol. 2002, 13:2648-2656.
14. Dar A.C., Shokat K.M. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling. Annu. Rev. Biochem. 2011, 80:769-795.
15. Day E., Waters B., Spiegel K., Alnadaf T., Manley P.W., Buchdunger E., Walker C., Jarai G. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib. Eur. J. Pharmacol. 2008, 599:44-53.
16. Dejmek J., Dib K., Jonsson M., Andersson T. Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion. Int. J. Cancer 2003, 103:344-351.
17. Endicott J.A., Noble M.E., Johnson L.N. The structural basis for control of eukaryotic protein kinases. Annu. Rev. Biochem. 2012, 81:587-613.
18. Eswaramoorthy R., Wang C.K., Chen W.C., Tang M.J., Ho M.L., Hwang C.C., Wang H.M., Wang C.Z. DDR1 regulates the stabilization of cell surface E-cadherin and E-cadherin-mediated cell aggregation. J. Cell. Physiol. 2010, 224:387-397.
19. Franco C., Hou G., Ahmad P.J., Fu E.Y., Koh L., Vogel W.F., Bendeck M.P. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Circ. Res. 2008, 102:1202-1211.
20. Franco C., Britto K., Wong E., Hou G., Zhu S.N., Chen M., Cybulsky M.I., Bendeck M.P. Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis. Circ. Res. 2009, 105:1141-1148.
21. Franco C., Ahmad P.J., Hou G., Wong E., Bendeck M.P. Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1. Circ. Res. 2010, 106:1775-1783.
22. Fu H.L., Sohail A., Valiathan R.R., Wasinski B.D., Kumarasiri M., Mahasenan K.V., Bernardo M.M., Tokmina-Roszyk D., Fields G.B., Mobashery S., Fridman R. Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases. J. Biol. Chem. 2013, 288:12114-12129.
23. Fu H.L., Valiathan R.R., Arkwright R., Sohail A., Mihai C., Kumarasiri M., Mahasenan K.V., Mobashery S., Huang P., Agarwal G., Fridman R. Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling. J. Biol. Chem. 2013, 288:7430-7437.
24. Gao M., Duan L., Luo J., Zhang L., Lu X., Zhang Y., Zhang Z., Tu Z., Xu Y., Ren X., Ding K. Discovery and optimization of 3-(2-(pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors. J. Med. Chem. 2013, 56:3281-3295.
25. Girgert R., Martin M., Kruegel J., Miosge N., Temme J., Eckes B., Muller G.A., Gross O. Integrin alpha2-deficient mice provide insights into specific functions of collagen receptors in the kidney. Fibrogenesis Tissue Repair 2010, 3:19.
26. Gross O., Beirowski B., Harvey S.J., McFadden C., Chen D., Tam S., Thorner P.S., Smyth N., Addicks K., Bloch W., Ninomiya Y., Sado Y., Weber M., Vogel W.F. DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria. Kidney Int. 2004, 66:102-111.
27. Gross O., Girgert R., Beirowski B., Kretzler M., Kang H.G., Kruegel J., Miosge N., Busse A.C., Segerer S., Vogel W.F., Muller G.A., Weber M. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease. Matrix Biol. 2010, 29:346-356.
28. Guerrot D., Kerroch M., Placier S., Vandermeersch S., Trivin C., Mael-Ainin M., Chatziantoniou C., Dussaule J.C. Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy. Am. J. Pathol. 2011, 179:83-91.
29. Hantschel O., Rix U., Superti-Furga G. Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib. Leuk. Lymphoma 2008, 49:615-619.
30. Hidalgo-Carcedo C., Hooper S., Chaudhry S.I., Williamson P., Harrington K., Leitinger B., Sahai E. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat. Cell Biol. 2011, 13:49-58.
31. Hou G., Vogel W., Bendeck M.P. The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. J. Clin. Invest. 2001, 107:727-735.
32. Ikeda K., Wang L.H., Torres R., Zhao H., Olaso E., Eng F.J., Labrador P., Klein R., Lovett D., Yancopoulos G.D., Friedman S.L., Lin H.C. Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen. J. Biol. Chem. 2002, 277:19206-19212.
33. Iwai L.K., Chang F., Huang P.H. Phosphoproteomic analysis identifies insulin enhancement of discoidin domain receptor 2 phosphorylation. Cell Adhes. Migr. 2013, 7:161-164.
34. Iwai L.K., Payne L.S., Luczynski M.T., Chang F., Xu H., Clinton R.W., Paul A., Esposito E.A., Gridley S., Leitinger B., Naegle K.M., Huang P.H. Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants. Biochem. J. 2013, 454:501-513.
35. Jonsson M., Andersson T. Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. J. Cell Sci. 2001, 114:2043-2053.
36. Kamohara H., Yamashiro S., Galligan C., Yoshimura T. Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes migration of leukocytes in three-dimensional collagen lattices. FASEB J. 2001, 15:2724-2726.
37. Kano K., Marin de Evsikova C., Young J., Wnek C., Maddatu T.P., Nishina P.M., Naggert J.K. A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse. Mol. Endocrinol. 2008, 22:1866-1880.
38. Kerroch M., Guerrot D., Vandermeersch S., Placier S., Mesnard L., Jouanneau C., Rondeau E., Ronco P., Boffa J.J., Chatziantoniou C., Dussaule J.C. Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis. FASEB J. 2012, 26:4079-4091.
39. Kim H.G., Hwang S.Y., Aaronson S.A., Mandinova A., Lee S.W. DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation. J. Biol. Chem. 2011, 286:17672-17681.
40. Kim H.G., Tan L., Weisberg E.L., Liu F., Canning P., Choi H.G., Ezell S.A., Wu H., Zhao Z., Wang J., Mandinova A., Griffin J.D., Bullock A.N., Liu Q., Lee S.W., Gray N.S. Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor. ACS Chem. Biol. 2013, 8(10):2145-4150.
41. Konitsiotis A.D., Raynal N., Bihan D., Hohenester E., Farndale R.W., Leitinger B. Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen. J. Biol. Chem. 2008, 283:6861-6868.
42. Koo D.H., McFadden C., Huang Y., Abdulhussein R., Friese-Hamim M., Vogel W.F. Pinpointing phosphotyrosine-dependent interactions downstream of the collagen receptor DDR1. FEBS Lett. 2006, 580:15-22.
43. Lee R., Eidman K.E., Kren S.M., Hostetter T.H., Segal Y. Localization of discoidin domain receptors in rat kidney. Nephron Exp. Nephrol. 2004, 97:e62-e70.
44. Lee J.E., Kang C.S., Guan X.Y., Kim B.T., Kim S.H., Lee Y.M., Moon W.S., Kim D.K. Discoidin domain receptor 2 is involved in the activation of bone marrow-derived dendritic cells caused by type I collagen. Biochem. Biophys. Res. Commun. 2007, 352:244-250.
45. Leitinger B. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2. J. Biol. Chem. 2003, 278:16761-16769.
46. Leitinger B. Transmembrane collagen receptors. Annu. Rev. Cell Dev. Biol. 2011, 27:265-290.
47. Leitinger B., Kwan A.P. The discoidin domain receptor DDR2 is a receptor for type X collagen. Matrix Biol. 2006, 25:355-364.
48. Lemeer S., Bluwstein A., Wu Z., Leberfinger J., Muller K., Kramer K., Kuster B. Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1. J. Proteomics 2012, 75:3465-3477.
49. Lemmon M.A., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010, 141:1117-1134.
50. L'Hote C.G., Thomas P.H., Ganesan T.S. Functional analysis of discoidin domain receptor 1: effect of adhesion on DDR1 phosphorylation. FASEB J. 2002, 16:234-236.
51. Liu Q., Sabnis Y., Zhao Z., Zhang T., Buhrlage S.J., Jones L.H., Gray N.S. Developing irreversible inhibitors of the protein kinase cysteinome. Chem. Biol. 2013, 20:146-159.
52. Lu K.K., Trcka D., Bendeck M.P. Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src. Cardiovasc. Pathol. 2011, 20:71-76.
53. Maeyama M., Koga H., Selvendiran K., Yanagimoto C., Hanada S., Taniguchi E., Kawaguchi T., Harada M., Ueno T., Sata M. Switching in discoid domain receptor expressions in SLUG-induced epithelial-mesenchymal transition. Cancer 2008, 113:2823-2831.
54. Miao L., Zhu S., Wang Y., Li Y., Ding J., Dai J., Cai H., Zhang D., Song Y. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition. Med. Oncol. 2013, 30:626.
55. Mihai C., Chotani M., Elton T.S., Agarwal G. Mapping of DDR1 distribution and oligomerization on the cell surface by FRET microscopy. J. Mol. Biol. 2009, 385:432-445.
56. Noordeen N.A., Carafoli F., Hohenester E., Horton M.A., Leitinger B. A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1. J. Biol. Chem. 2006, 281:22744-22751.
57. Olaso E., Ikeda K., Eng F.J., Xu L., Wang L.H., Lin H.C., Friedman S.L. DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J. Clin. Invest. 2001, 108:1369-1378.
58. Olaso E., Labrador J.P., Wang L., Ikeda K., Eng F.J., Klein R., Lovett D.H., Lin H.C., Friedman S.L. Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. J. Biol. Chem. 2002, 277:3606-3613.
59. Olaso E., Arteta B., Benedicto A., Crende O., Friedman S.L. Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages. Am. J. Pathol. 2011, 179:2894-2904.
60. Perez J.L., Shen X., Finkernagel S., Sciorra L., Jenkins N.A., Gilbert D.J., Copeland N.G., Wong T.W. Identification and chromosomal mapping of a receptor tyrosine kinase with a putative phospholipid binding sequence in its ectodomain. Oncogene 1994, 9:211-219.
61. Perez J.L., Jing S.Q., Wong T.W. Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines. Oncogene 1996, 12:1469-1477.
62. Ram R., Lorente G., Nikolich K., Urfer R., Foehr E., Nagavarapu U. Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2. J. Neurooncol. 2006, 76:239-248.
63. Ren T., Zhang J., Liu X., Yao L. Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients. Med. Oncol. 2013, 30:397.
64. Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.L., Polakiewicz R.D., Rush J., Comb M.J. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
65. Roarty K., Serra R. Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth. Development 2007, 134:3929-3939.
66. Schminke B., Muhammad H., Bode C., Sadowski B., Gerter R., Gersdorff N., Burgers R., Monsonego-Ornan E., Rosen V., Miosge N. A discoidin domain receptor 1 knock-out mouse as a novel model for osteoarthritis of the temporomandibular joint. Cell. Mol. Life Sci. 2013 Aug 4, [Epub ahead of print] PMID:23912900.
67. Shintani Y., Fukumoto Y., Chaika N., Svoboda R., Wheelock M.J., Johnson K.R. Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J. Cell Biol. 2008, 180:1277-1289.
68. Shrivastava A., Radziejewski C., Campbell E., Kovac L., McGlynn M., Ryan T.E., Davis S., Goldfarb M.P., Glass D.J., Lemke G., Yancopoulos G.D. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol. Cell 1997, 1:25-34.
69. Siddiqui K., Kim G.W., Lee D.H., Shin H.R., Yang E.G., Lee N.T., Yang B.S. Actinomycin D identified as an inhibitor of discoidin domain receptor 2 interaction with collagen through an insect cell based screening of a drug compound library. Biol. Pharm. Bull. 2009, 32:136-141.
70. Smyth L.A., Collins I. Measuring and interpreting the selectivity of protein kinase inhibitors. J. Chem. Biol. 2009, 2:131-151.
71. Suh H.N., Han H.J. Collagen I regulates the self-renewal of mouse embryonic stem cells through alpha2beta1 integrin- and DDR1-dependent Bmi-1. J. Cell. Physiol. 2011, 226:3422-3432.
72. Sunk I.G., Bobacz K., Hofstaetter J.G., Amoyo L., Soleiman A., Smolen J., Xu L., Li Y. Increased expression of discoidin domain receptor 2 is linked to the degree of cartilage damage in human knee joints: a potential role in osteoarthritis pathogenesis. Arthritis Rheum. 2007, 56:3685-3692.
73. Taylor S.S., Kornev A.P. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem. Sci. 2011, 36:65-77.
74. Tokarski J.S., Newitt J.A., Chang C.Y., Cheng J.D., Wittekind M., Kiefer S.E., Kish K., Lee F.Y., Borzillerri R., Lombardo L.J., Xie D., Zhang Y., Klei H.E. The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants. Cancer Res. 2006, 66:5790-5797.
75. Underwood D.C., Osborn R.R., Bochnowicz S., Webb E.F., Rieman D.J., Lee J.C., Romanic A.M., Adams J.L., Hay D.W., Griswold D.E. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L895-L902.
76. Valiathan R.R., Marco M., Leitinger B., Kleer C.G., Fridman R. Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev. 2012, 31:295-321.
77. Vogel W., Gish G.D., Alves F., Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1997, 1:13-23.
78. Vogel W., Brakebusch C., Fassler R., Alves F., Ruggiero F., Pawson T. Discoidin domain receptor 1 is activated independently of beta(1) integrin. J. Biol. Chem. 2000, 275:5779-5784.
79. Vogel W.F., Aszodi A., Alves F., Pawson T. Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol. Cell. Biol. 2001, 21:2906-2917.
80. Walsh L.A., Nawshad A., Medici D. Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition. Matrix Biol. 2011, 30:243-247.
81. Wang C.Z., Su H.W., Hsu Y.C., Shen M.R., Tang M.J. A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration. Mol. Biol. Cell 2006, 17:2839-2852.
82. Xu L., Peng H., Wu D., Hu K., Goldring M.B., Olsen B.R., Li Y. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J. Biol. Chem. 2005, 280:548-555.
83. Xu L., Peng H., Glasson S., Lee P.L., Hu K., Ijiri K., Olsen B.R., Goldring M.B., Li Y. Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. Arthritis Rheum. 2007, 56:2663-2673.
84. Xu L., Servais J., Polur I., Kim D., Lee P.L., Chung K., Li Y. Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice. Arthritis Rheum. 2010, 62:2736-2744.
85. Xu H., Raynal N., Stathopoulos S., Myllyharju J., Farndale R.W., Leitinger B. Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1. Matrix Biol. 2011, 30:16-26.
86. Xu L., Polur I., Servais J.M., Hsieh S., Lee P.L., Goldring M.B., Li Y. Intact pericellular matrix of articular cartilage is required for unactivated discoidin domain receptor 2 in the mouse model. Am. J. Pathol. 2011, 179:1338-1346.
87. Xu H., Bihan D., Chang F., Huang P.H., Farndale R.W., Leitinger B. Discoidin domain receptors promote alpha1beta1- and alpha2beta1-integrin mediated cell adhesion to collagen by enhancing integrin activation. PLoS ONE 2012, 7:e52209.
88. Yang K., Kim J.H., Kim H.J., Park I.S., Kim I.Y., Yang B.S. Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src stimulates intramolecular autophosphorylation and Shc signaling complex formation. J. Biol. Chem. 2005, 280:39058-39066.
89. Yeh Y.C., Wang C.Z., Tang M.J. Discoidin domain receptor 1 activation suppresses alpha2beta1 integrin-dependent cell spreading through inhibition of Cdc42 activity. J. Cell. Physiol. 2009, 218:146-156.
90. Yeh Y.C., Lin H.H., Tang M.J. A tale of two collagen receptors, integrin beta1 and discoidin domain receptor 1, in epithelial cell differentiation. Am. J. Physiol. Cell Physiol. 2012, 303:C1207-C1217.
91. Zhang J., Yang P.L., Gray N.S. Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer 2009, 9:28-39.
92. Zhang K., Corsa C.A., Ponik S.M., Prior J.L., Piwnica-Worms D., Eliceiri K.W., Keely P.J., Longmore G.D. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat. Cell Biol. 2013, 15:677-687.
93. Zhang S., Bu X., Zhao H., Yu J., Wang Y., Li D., Zhu C., Zhu T., Ren T., Liu X., Yao L., Su J. A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumor angiogenesis and metastasis. J. Pathol. 2013, 10.1002/path.4311.